Dr. Wassim Kassouf
- Professor and Chair, Division of Urology
- Elhilali-Azrieli Chair in Urologic Sciences
- Associate Member, Pathology
MD, CM, FRCSC
Currently supervising students
- Development and evaluation of organ-preservation strategies in bladder cancer
- Identification and validation of predictive biomarkers of treatment response in bladder cancer
- Clinical outcomes research, quality improvement, and patterns of care in urologic oncology
- Management of urologic malignancies
- Robotic, laparoscopic, and open oncologic surgery
Cancer, GU
Dr. Wassim Kassouf is a tenured Professor and Chair of the Division of Urology at McGill University and McGill University Health Centre. A McGill alumnus, he completed his medical school and urology residency training at McGill before pursuing a fellowship in urologic oncology at The University of Texas MD Anderson Cancer Center in Houston, Texas. Dr. Kassouf’s clinical practice encompasses all aspects of urologic oncology, while his clinical and translational research focuses primarily on advancing organ-preservation strategies for bladder cancer. A dedicated leader within the McGill community, he previously served as Vice-Chair of Academic Affairs for the Department of Surgery at McGill University, Urology Residency Program Director, and a member of the Royal College Examination Committee.
Nationally and internationally, Dr. Kassouf is Past-President of the Canadian Urological Association, co-founder of Bladder Cancer Canada, Genitourinary Co-Chair of the Canadian Cancer Trials Group (CCTG), and an executive member of the National Institutes of Health Genitourinary Steering Committee. As a surgeon-scientist, he has led the development of multiple national clinical guidelines aimed at improving the quality of care for patients with urologic cancers. He has authored more than 450 peer-reviewed manuscripts and book chapters, with sustained independent funding from prestigious organizations including the U.S. Department of Defense, the Canadian Institutes of Health Research, and the Cancer Research Society. He is the current Bladder Cancer Section Editor of the Canadian Urological Association Journal and previously served as Associate Editor for BMC Urology. He is a graduate of the AUA Leadership Program. His contributions to research, education, and urologic oncology have been recognized through several awards, including the American Urological Association Young Urologist of the Year Award, Bladder Cancer Canada Medical Leadership Award, Everett C. Reid Teaching Excellence Award, and FRQS Quebec Distinguished Research Scholar Award (FRQS chercheurs-boursiers de mérite).